-
1
-
-
0035941384
-
Drug-resistant mutants of HIV-1 in patients exhibiting increasing CD4 cell count despite virological failure of highly active antiretroviral therapy
-
Antinori, A., Liuzzi, G., Cingolani, A., Bertoli, A., Di Giambenedetto, S., Trotta, M.P., Rizzo, M.G., Girardi, E., De Luca, A., Perno, C.F., 2001. Drug-resistant mutants of HIV-1 in patients exhibiting increasing CD4 cell count despite virological failure of highly active antiretroviral therapy. AIDS 15, 2325-2327.
-
(2001)
AIDS
, vol.15
, pp. 2325-2327
-
-
Antinori, A.1
Liuzzi, G.2
Cingolani, A.3
Bertoli, A.4
Di Giambenedetto, S.5
Trotta, M.P.6
Rizzo, M.G.7
Girardi, E.8
De Luca, A.9
Perno, C.F.10
-
2
-
-
0033863784
-
Mutants of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase resistant to nonnucleoside reverse transcriptase inhibitors demonstrate altered rates of RNase H cleavage that correlate with HIV-1 replication fitness in cell culture
-
Archer, R.H., Dykes, C., Gerondelis, P., Lloyd, A., Fay, P., Reichman, R.C., Bambara, R.A., Demeter, L.M., 2000. Mutants of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase resistant to nonnucleoside reverse transcriptase inhibitors demonstrate altered rates of RNase H cleavage that correlate with HIV-1 replication fitness in cell culture. J. Virol. 74, 8390-8401.
-
(2000)
J. Virol.
, vol.74
, pp. 8390-8401
-
-
Archer, R.H.1
Dykes, C.2
Gerondelis, P.3
Lloyd, A.4
Fay, P.5
Reichman, R.C.6
Bambara, R.A.7
Demeter, L.M.8
-
3
-
-
12244301338
-
-
Barcelona, Spain
-
Arts, E.J., Ball, S.C., Abraha, A., 2002. Ex vivo fitness studies provides evidence of the natural attenuation of human immunodeficiency virus type 1 subtype C during the AIDS epidemic, Barcelona, Spain. pp. 349-350.
-
(2002)
Ex Vivo Fitness Studies Provides Evidence of the Natural Attenuation of Human Immunodeficiency Virus Type 1 Subtype C During the AIDS Epidemic
, pp. 349-350
-
-
Arts, E.J.1
Ball, S.C.2
Abraha, A.3
-
4
-
-
0032869255
-
HIV-1 evolution under pressure of protease inhibitors: Climbing the stairs of viral fitness
-
Berkhout, B., 1999a. HIV-1 evolution under pressure of protease inhibitors: climbing the stairs of viral fitness. J. Biomed. Sci. 6, 298-305.
-
(1999)
J. Biomed. Sci.
, vol.6
, pp. 298-305
-
-
Berkhout, B.1
-
5
-
-
0033081160
-
Proposed alternatives for the use of anti-HIV drugs
-
Berkhout, B., 1999b. Proposed alternatives for the use of anti-HIV drugs. Drug Resist. Updat. 2, 69-70.
-
(1999)
Drug Resist. Updat.
, vol.2
, pp. 69-70
-
-
Berkhout, B.1
-
6
-
-
0035958763
-
Kinetics of HIV-1 RNA and resistance-associated mutations after cessation of antiretroviral combination therapy
-
Birk, M., Svedhem, V., Sonnerborg, A., 2001. Kinetics of HIV-1 RNA and resistance-associated mutations after cessation of antiretroviral combination therapy. AIDS 15, 1359-1368.
-
(2001)
AIDS
, vol.15
, pp. 1359-1368
-
-
Birk, M.1
Svedhem, V.2
Sonnerborg, A.3
-
7
-
-
0031884993
-
In vitro replication kinetics of human immunodeficiency virus type 1 (HIV-1) variants in relation to virus load in long-term survivors of HIV-1 infection
-
Blaak, H., Brouwer, M., Ran, L.J., de Wolf, F., Schuitemaker, H., 1998. In vitro replication kinetics of human immunodeficiency virus type 1 (HIV-1) variants in relation to virus load in long-term survivors of HIV-1 infection. J. Infect. Dis. 177, 600-610.
-
(1998)
J. Infect. Dis.
, vol.177
, pp. 600-610
-
-
Blaak, H.1
Brouwer, M.2
Ran, L.J.3
De Wolf, F.4
Schuitemaker, H.5
-
8
-
-
0035104646
-
Individual contributions of mutant protease and reverse transcriptase to viral infectivity, replication, and protein maturation of antiretroviral drug-resistant human immunodeficiency virus type 1
-
Bleiber, G., Munoz, M., Ciuffi, A., Meylan, P., Telenti, A., 2001. Individual contributions of mutant protease and reverse transcriptase to viral infectivity, replication, and protein maturation of antiretroviral drug-resistant human immunodeficiency virus type 1. J. Virol. 75, 3291-3300.
-
(2001)
J. Virol.
, vol.75
, pp. 3291-3300
-
-
Bleiber, G.1
Munoz, M.2
Ciuffi, A.3
Meylan, P.4
Telenti, A.5
-
9
-
-
0030065565
-
Resistance of human immunodeficiency virus type 1 to protease inhibitors: Selection of resistance mutations in the presence and absence of the drug
-
Borman, A.M., Paulous, S., Clavel, F., 1996. Resistance of human immunodeficiency virus type 1 to protease inhibitors: selection of resistance mutations in the presence and absence of the drug. J. Gen. Virol. 77, 419-426.
-
(1996)
J. Gen. Virol.
, vol.77
, pp. 419-426
-
-
Borman, A.M.1
Paulous, S.2
Clavel, F.3
-
10
-
-
0034843933
-
Viral evolution in response to the broad-based retroviral protease inhibitor TL-3
-
Buhler, B., Lin, Y.C., Morris, G., Olson, A.J., Wong, C.H., Richman, D.D., Elder, J.H., Torbett, B.E., 2001. Viral evolution in response to the broad-based retroviral protease inhibitor TL-3. J. Virol. 75, 9502-9508.
-
(2001)
J. Virol.
, vol.75
, pp. 9502-9508
-
-
Buhler, B.1
Lin, Y.C.2
Morris, G.3
Olson, A.J.4
Wong, C.H.5
Richman, D.D.6
Elder, J.H.7
Torbett, B.E.8
-
11
-
-
0034565934
-
HIV drug resistance and viral fitness
-
Clavel, F., Race, E., Mammano, F., 2000. HIV drug resistance and viral fitness. Adv. Pharmacol. 49, 41-66.
-
(2000)
Adv. Pharmacol.
, vol.49
, pp. 41-66
-
-
Clavel, F.1
Race, E.2
Mammano, F.3
-
12
-
-
0028952146
-
HIV population dynamics in vivo: Implications for genetic variation, pathogenesis, and therapy
-
Coffin, J.M., 1995. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 267, 483-489.
-
(1995)
Science
, vol.267
, pp. 483-489
-
-
Coffin, J.M.1
-
13
-
-
0031015475
-
Impaired fitness of human immunodeficiency virus type 1 variants with high-level resistance to protease inhibitors
-
Croteau, G., Doyon, L., Thibeault, D., McKercher, G., Pilote, L., Lamarre, D., 1997. Impaired fitness of human immunodeficiency virus type 1 variants with high-level resistance to protease inhibitors. J. Virol. 71, 1089-1096.
-
(1997)
J. Virol.
, vol.71
, pp. 1089-1096
-
-
Croteau, G.1
Doyon, L.2
Thibeault, D.3
McKercher, G.4
Pilote, L.5
Lamarre, D.6
-
14
-
-
0035158709
-
Establishment of new transmissible and drug-sensitive human immunodeficiency virus type 1 wild types due to transmission of nucleoside analogue-resistant virus
-
De Ronde, A., van Dooren, M., van Der, H.L., Bouwhuis, D., de Rooij, E., van Gemen, B., de Boer, R., Goudsmit, J., 2001. Establishment of new transmissible and drug-sensitive human immunodeficiency virus type 1 wild types due to transmission of nucleoside analogue-resistant virus. J. Virol. 75, 595-602.
-
(2001)
J. Virol.
, vol.75
, pp. 595-602
-
-
De Ronde, A.1
Van Dooren, M.2
Van Der, H.L.3
Bouwhuis, D.4
De Rooij, E.5
Van Gemen, B.6
De Boer, R.7
Goudsmit, J.8
-
15
-
-
0034456413
-
Determinants of virological response to antiretroviral therapy: Implications for long-term strategies
-
Deeks, S.G., 2000. Determinants of virological response to antiretroviral therapy: implications for long-term strategies. Clin. Infect. Dis. 30 (Suppl. 2), S177-S184.
-
(2000)
Clin. Infect. Dis.
, vol.30
, Issue.SUPPL. 2
-
-
Deeks, S.G.1
-
16
-
-
0035281213
-
International perspectives on antiretroviral resistance. Nonnucleoside reverse transcriptase inhibitor resistance
-
Deeks, S.G., 2001. International perspectives on antiretroviral resistance. Nonnucleoside reverse transcriptase inhibitor resistance. J. Acquir. Immune. Defic. Syndr. 26 (Suppl. 1), S25-S33.
-
(2001)
J. Acquir. Immune. Defic. Syndr.
, vol.26
, Issue.SUPPL. 1
-
-
Deeks, S.G.1
-
17
-
-
0034070773
-
Sustained CD4+ T cell response after virologic failure of protease inhibitor-based regimens in patients with human immunodeficiency virus infection
-
Deeks, S.G., Barbour, J.D., Martin, J.N., Swanson, M.S., Grant, R.M., 2000. Sustained CD4+ T cell response after virologic failure of protease inhibitor-based regimens in patients with human immunodeficiency virus infection. J. Infect. Dis. 181, 946-953.
-
(2000)
J. Infect. Dis.
, vol.181
, pp. 946-953
-
-
Deeks, S.G.1
Barbour, J.D.2
Martin, J.N.3
Swanson, M.S.4
Grant, R.M.5
-
18
-
-
0035864943
-
Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia
-
Deeks, S.G., Wrin, T., Liegler, T., Hoh, R., Hayden, M., Barbour, J.D., Hellmann, N.S., Petropoulos, C.J., McCune, J.M., Hellerstein, M.K., Grant, R.M., 2001. Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia. N. Engl. J. Med. 344, 472-480.
-
(2001)
N. Engl. J. Med.
, vol.344
, pp. 472-480
-
-
Deeks, S.G.1
Wrin, T.2
Liegler, T.3
Hoh, R.4
Hayden, M.5
Barbour, J.D.6
Hellmann, N.S.7
Petropoulos, C.J.8
McCune, J.M.9
Hellerstein, M.K.10
Grant, R.M.11
-
19
-
-
0034867418
-
Replicative fitness in vivo of HIV-1 variants with multiple drug resistance-associated mutations
-
Devereux, H.L., Emery, V.C., Johnson, M.A., Loveday, C., 2001. Replicative fitness in vivo of HIV-1 variants with multiple drug resistance-associated mutations. J. Med. Virol. 65, 218-224.
-
(2001)
J. Med. Virol.
, vol.65
, pp. 218-224
-
-
Devereux, H.L.1
Emery, V.C.2
Johnson, M.A.3
Loveday, C.4
-
20
-
-
0034691650
-
Substantial correlation between HIV type 1 drug-associated resistance mutations in plasma and peripheral blood mononuclear cells in treatment-experienced patients
-
Devereux, H.L., Loveday, C., Youle, M., Sabin, C.A., Burke, A., Johnson, M., 2000. Substantial correlation between HIV type 1 drug-associated resistance mutations in plasma and peripheral blood mononuclear cells in treatment-experienced patients. AIDS Res. Hum. Retroviruses 16, 1025-1030.
-
(2000)
AIDS Res. Hum. Retroviruses
, vol.16
, pp. 1025-1030
-
-
Devereux, H.L.1
Loveday, C.2
Youle, M.3
Sabin, C.A.4
Burke, A.5
Johnson, M.6
-
21
-
-
0034630910
-
Viruses at the edge of adaptation
-
Domingo, E., 2000. Viruses at the edge of adaptation. Virology 270, 251-253.
-
(2000)
Virology
, vol.270
, pp. 251-253
-
-
Domingo, E.1
-
22
-
-
0002482572
-
Viral quasispecies and fitness variations
-
Domingo, E., Webster, R., Holland, J. (Eds.), Academic Press, San Diego
-
Domingo, E., Escarmis, C., Menendez-Arias, L., Holland, J., 1999. Viral quasispecies and fitness variations. In: Domingo, E., Webster, R., Holland, J. (Eds.), Origin and Evolution of Viruses. Academic Press, San Diego, pp. 141-161.
-
(1999)
Origin and Evolution of Viruses
, pp. 141-161
-
-
Domingo, E.1
Escarmis, C.2
Menendez-Arias, L.3
Holland, J.4
-
23
-
-
0030747157
-
RNA virus mutations and fitness for survival
-
Domingo, E., Holland, J.J., 1997. RNA virus mutations and fitness for survival. Annu. Rev. Microbiol. 51, 151-178.
-
(1997)
Annu. Rev. Microbiol.
, vol.51
, pp. 151-178
-
-
Domingo, E.1
Holland, J.J.2
-
24
-
-
0029899093
-
Second locus involved in human immunodeficiency virus type 1 resistance to protease inhibitors
-
Doyon, L., Croteau, G., Thibeault, D., Poulin, F., Pilote, L., Lamarre, D., 1996. Second locus involved in human immunodeficiency virus type 1 resistance to protease inhibitors. J. Virol. 70, 3763-3769.
-
(1996)
J. Virol.
, vol.70
, pp. 3763-3769
-
-
Doyon, L.1
Croteau, G.2
Thibeault, D.3
Poulin, F.4
Pilote, L.5
Lamarre, D.6
-
25
-
-
0031950370
-
Genotypic changes in human immunodeficiency virus type I associated with loss of suppression of plasma viral RNA levels in subjects treated with ritonavir (Norvir) monotherapy
-
Eastman, P.S., Mittler, J., Kelso, R., Gee, C., Boyer, E., Kolberg, J., Urdea, M., Leonard, J.M., Norbeck, D.W., Mo, H., Markowitz, M., 1998. Genotypic changes in human immunodeficiency virus type I associated with loss of suppression of plasma viral RNA levels in subjects treated with ritonavir (Norvir) monotherapy. J. Virol. 72, 5154-5164.
-
(1998)
J. Virol.
, vol.72
, pp. 5154-5164
-
-
Eastman, P.S.1
Mittler, J.2
Kelso, R.3
Gee, C.4
Boyer, E.5
Kolberg, J.6
Urdea, M.7
Leonard, J.M.8
Norbeck, D.W.9
Mo, H.10
Markowitz, M.11
-
26
-
-
0029067916
-
Comparison of selective polymerase chain reaction primers and differential probe hybridization of polymerase chain reaction products for determination of relative amounts of codon 215 mutant and wild-type HIV-1 populations
-
Eastman, P.S., Urdea, M., Besemer, D., Stempien, M., Kolberg, J., 1995. Comparison of selective polymerase chain reaction primers and differential probe hybridization of polymerase chain reaction products for determination of relative amounts of codon 215 mutant and wild-type HIV-1 populations. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 9, 264-273.
-
(1995)
J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol.
, vol.9
, pp. 264-273
-
-
Eastman, P.S.1
Urdea, M.2
Besemer, D.3
Stempien, M.4
Kolberg, J.5
-
27
-
-
0033819048
-
Evidence of a role for the Q151L mutation and the viral background in development of multiple dideoxynucleoside-resistant human immunodeficiency virus type 1
-
Garcia-Lerma, J.G., Gerrish, P.J., Wright, A.C., Qari, S.H., Heneine, W., 2000. Evidence of a role for the Q151L mutation and the viral background in development of multiple dideoxynucleoside-resistant human immunodeficiency virus type 1. J. Virol. 74, 9339-9346.
-
(2000)
J. Virol.
, vol.74
, pp. 9339-9346
-
-
Garcia-Lerma, J.G.1
Gerrish, P.J.2
Wright, A.C.3
Qari, S.H.4
Heneine, W.5
-
28
-
-
0032993043
-
The P236L delavirdine-resistant human immunodeficiency virus type 1 mutant is replication defective and demonstrates alterations in both RNA 5′-end- and DNA 3′-end-directed RNase H activities
-
Gerondelis, P., Archer, R.H., Palaniappan, C., Reichman, R.C., Fay, P.J., Bambara, R.A., Demeter, L.M., 1999. The P236L delavirdine-resistant human immunodeficiency virus type 1 mutant is replication defective and demonstrates alterations in both RNA 5′-end- and DNA 3′-end-directed RNase H activities. J. Virol. 73, 5803-5813.
-
(1999)
J. Virol.
, vol.73
, pp. 5803-5813
-
-
Gerondelis, P.1
Archer, R.H.2
Palaniappan, C.3
Reichman, R.C.4
Fay, P.J.5
Bambara, R.A.6
Demeter, L.M.7
-
29
-
-
0030926277
-
Broad spectrum of in vivo fitness of human immunodeficiency virus type 1 subpopulations differing at reverse transcriptase codons 41 and 215
-
Goudsmit, J., De Ronde, A., de Rooij, E., de Boer, R., 1997. Broad spectrum of in vivo fitness of human immunodeficiency virus type 1 subpopulations differing at reverse transcriptase codons 41 and 215. J. Virol. 71, 4479-4484.
-
(1997)
J. Virol.
, vol.71
, pp. 4479-4484
-
-
Goudsmit, J.1
De Ronde, A.2
De Rooij, E.3
De Boer, R.4
-
30
-
-
0030011523
-
Human immunodeficiency virus fitness in vivo: Calculations based on a single zidovudine resistance mutation at codon 215 of reverse transcriptase
-
Goudsmit, J., De Ronde, A., Ho, D.D., Perelson, A.S., 1996. Human immunodeficiency virus fitness in vivo: calculations based on a single zidovudine resistance mutation at codon 215 of reverse transcriptase. J. Virol. 70 (8), 5662-5664.
-
(1996)
J. Virol.
, vol.70
, Issue.8
, pp. 5662-5664
-
-
Goudsmit, J.1
De Ronde, A.2
Ho, D.D.3
Perelson, A.S.4
-
31
-
-
12244290726
-
Large fitness differences between protease inhibitor susceptible and resistant HIV-1 in vivo
-
Grant, R.M., Liegler, T., Bonhoeffer, S., Elkin, C., Nijjar, S., Wrin, T., Ho, R., Kolberg, J., Hellerstein, M.K., Hellmann, N.S., Petropoulos, C.J., Deeks, S.G., 2001. Large fitness differences between protease inhibitor susceptible and resistant HIV-1 in vivo. In: Proceedings of the 8th Annual HIV Dynamics and Evolution Meeting.
-
(2001)
Proceedings of the 8th Annual HIV Dynamics and Evolution Meeting
-
-
Grant, R.M.1
Liegler, T.2
Bonhoeffer, S.3
Elkin, C.4
Nijjar, S.5
Wrin, T.6
Ho, R.7
Kolberg, J.8
Hellerstein, M.K.9
Hellmann, N.S.10
Petropoulos, C.J.11
Deeks, S.G.12
-
32
-
-
0034987622
-
Changes in human immunodeficiency virus type 1 populations after treatment interruption in patients failing antiretroviral therapy
-
Hance, A.J., Lemiale, V., Izopet, J., Lecossier, D., Joly, V., Massip, P., Mammano, F., Descamps, D., Brun-Vezinet, F., Clavel, F., 2001. Changes in human immunodeficiency virus type 1 populations after treatment interruption in patients failing antiretroviral therapy. J. Virol. 75, 6410-6417.
-
(2001)
J. Virol.
, vol.75
, pp. 6410-6417
-
-
Hance, A.J.1
Lemiale, V.2
Izopet, J.3
Lecossier, D.4
Joly, V.5
Massip, P.6
Mammano, F.7
Descamps, D.8
Brun-Vezinet, F.9
Clavel, F.10
-
33
-
-
0031958266
-
Relative replicative fitness of zidovudine-resistant human immunodeficiency virus type 1 isolates in vitro
-
Harrigan, P.R., Bloor, S., Larder, B.A., 1998. Relative replicative fitness of zidovudine-resistant human immunodeficiency virus type 1 isolates in vitro. J. Virol. 72, 3773-3778.
-
(1998)
J. Virol.
, vol.72
, pp. 3773-3778
-
-
Harrigan, P.R.1
Bloor, S.2
Larder, B.A.3
-
34
-
-
0029798237
-
Nevirapineresistant human immunodeficiency virus: Kinetics of replication and estimated prevalence in untreated patients
-
Havlir, D.V., Eastman, S., Gamst, A., Richman, D.D., 1996. Nevirapineresistant human immunodeficiency virus: kinetics of replication and estimated prevalence in untreated patients. J. Virol. 70, 7894-7899.
-
(1996)
J. Virol.
, vol.70
, pp. 7894-7899
-
-
Havlir, D.V.1
Eastman, S.2
Gamst, A.3
Richman, D.D.4
-
35
-
-
0344474694
-
A rapid method for simultaneous detection of phenotypic resistance to inhibitors of protease and reverse transcriptase in recombinant human immunodeficiency virus type 1 isolates from patients treated with antiretroviral drugs
-
Hertogs, K., de Bethune, M.P., Miller, V., Ivens, T., Schel, P., Van Cauwenberge, A., Van Den, E.C., Van, G., Azijn, H., Van Houtte, M., Peeters, F., Staszewski, S., Conant, M., Bloor, S., Kemp, S., Larder, B., Pauwels, R., 1998. A rapid method for simultaneous detection of phenotypic resistance to inhibitors of protease and reverse transcriptase in recombinant human immunodeficiency virus type 1 isolates from patients treated with antiretroviral drugs. Antimicrob. Agents Chemother. 42, 269-276.
-
(1998)
Antimicrob. Agents Chemother.
, vol.42
, pp. 269-276
-
-
Hertogs, K.1
De Bethune, M.P.2
Miller, V.3
Ivens, T.4
Schel, P.5
Van Cauwenberge, A.6
Van Den, E.C.7
Van, G.8
Azijn, H.9
Van Houtte, M.10
Peeters, F.11
Staszewski, S.12
Conant, M.13
Bloor, S.14
Kemp, S.15
Larder, B.16
Pauwels, R.17
-
36
-
-
17344390474
-
Antiretroviral drug resistance testing in adults with HIV infection: Implications for clinical management
-
International AIDS Society USA Panel
-
Hirsch, M.S., Conway, B., D'aquila, R.T., Johnson, V.A., Brun-Vezinet, F., Clotet, B., Demeter, L.M., Hammer, S.M., Jacobsen, D.M., Kuritzkes, D.R., Loveday, C., Mellors, J.W., Vella, S., Richman, D.D., 1998. Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society USA Panel. JAMA 279, 1984-1991.
-
(1998)
JAMA
, vol.279
, pp. 1984-1991
-
-
Hirsch, M.S.1
Conway, B.2
D'aquila, R.T.3
Johnson, V.A.4
Brun-Vezinet, F.5
Clotet, B.6
Demeter, L.M.7
Hammer, S.M.8
Jacobsen, D.M.9
Kuritzkes, D.R.10
Loveday, C.11
Mellors, J.W.12
Vella, S.13
Richman, D.D.14
-
37
-
-
0028014288
-
Characterization of human immunodeficiency virus type 1 variants with increased resistance to a C2-symmetric protease inhibitor
-
Ho, D.D., Toyoshima, T., Mo, H., Kempf, D.J., Norbeck, D., Chen, C.M., Wideburg, N.E., Burt, S.K., Erickson, J.W., Singh, M.K., 1994. Characterization of human immunodeficiency virus type 1 variants with increased resistance to a C2-symmetric protease inhibitor. J. Virol. 68, 2016-2020.
-
(1994)
J. Virol.
, vol.68
, pp. 2016-2020
-
-
Ho, D.D.1
Toyoshima, T.2
Mo, H.3
Kempf, D.J.4
Norbeck, D.5
Chen, C.M.6
Wideburg, N.E.7
Burt, S.K.8
Erickson, J.W.9
Singh, M.K.10
-
38
-
-
0026070176
-
Quantitation of relative fitness and great adaptability of clonal populations of RNA viruses
-
Holland, J.J., de la Torre, J.C., Clarke, D.K., Duarte, E., 1991. Quantitation of relative fitness and great adaptability of clonal populations of RNA viruses. J. Virol. 65, 2960-2967.
-
(1991)
J. Virol.
, vol.65
, pp. 2960-2967
-
-
Holland, J.J.1
De la Torre, J.C.2
Clarke, D.K.3
Duarte, E.4
-
39
-
-
0036135710
-
In vitro analysis of HIV-1 resistance to nevirapine and fitness determination of resistant variants
-
Iglesias-Ussel, M.D., Casado, C., Yuste, E., Olivares, I., Lopez-Galindez, C., 2002. In vitro analysis of HIV-1 resistance to nevirapine and fitness determination of resistant variants. J. Gen. Virol. 83, 93-101.
-
(2002)
J. Gen. Virol.
, vol.83
, pp. 93-101
-
-
Iglesias-Ussel, M.D.1
Casado, C.2
Yuste, E.3
Olivares, I.4
Lopez-Galindez, C.5
-
40
-
-
0034469498
-
Relative replication fitness of a high-level 3′-azido-3′-deoxythymidine-resistant variant of human immunodeficiency virus type 1 possessing an amino acid deletion at codon 67 and a novel substitution (Thr → Gly) at codon 69
-
Imamichi, T., Berg, S.C., Imamichi, H., Lopez, J.C., Metcalf, J.A., Falloon, J., Lane, H.C., 2000. Relative replication fitness of a high-level 3′-azido-3′-deoxythymidine-resistant variant of human immunodeficiency virus type 1 possessing an amino acid deletion at codon 67 and a novel substitution (Thr → Gly) at codon 69. J. Virol. 74, 10958-10964.
-
(2000)
J. Virol.
, vol.74
, pp. 10958-10964
-
-
Imamichi, T.1
Berg, S.C.2
Imamichi, H.3
Lopez, J.C.4
Metcalf, J.A.5
Falloon, J.6
Lane, H.C.7
-
41
-
-
0035088519
-
Amino acid deletion at codon 67 and Thr-to-Gly change at codon 69 of human immunodeficiency virus type 1 reverse transcriptase confer novel drug resistance profiles
-
Imamichi, T., Murphy, M.A., Imamichi, H., Lane, H.C., 2001. Amino acid deletion at codon 67 and Thr-to-Gly change at codon 69 of human immunodeficiency virus type 1 reverse transcriptase confer novel drug resistance profiles. J. Virol. 75, 3988-3992.
-
(2001)
J. Virol.
, vol.75
, pp. 3988-3992
-
-
Imamichi, T.1
Murphy, M.A.2
Imamichi, H.3
Lane, H.C.4
-
42
-
-
0028085161
-
Recombinant virus assay: A rapid, phenotypic assay for assessment of drug susceptibility of human immunodeficiency virus type 1 isolates
-
Kellam, P., Larder, B.A., 1994. Recombinant virus assay: a rapid, phenotypic assay for assessment of drug susceptibility of human immunodeficiency virus type 1 isolates. Antimicrob. Agents Chemother. 38, 23-30.
-
(1994)
Antimicrob. Agents Chemother.
, vol.38
, pp. 23-30
-
-
Kellam, P.1
Larder, B.A.2
-
43
-
-
0036655272
-
Origin of human immunodeficiency virus type 1 quasispecies emerging after antiretroviral treatment interruption in patients with therapeutic failure
-
Kijak, G.H., Simon, V., Balfe, P., Vanderhoeven, J., Pampuro, S.E., Zala, C., Ochoa, C., Cahn, P., Markowitz, M., Salomon, H., 2002. Origin of human immunodeficiency virus type 1 quasispecies emerging after antiretroviral treatment interruption in patients with therapeutic failure. J. Virol. 76, 7000-7009.
-
(2002)
J. Virol.
, vol.76
, pp. 7000-7009
-
-
Kijak, G.H.1
Simon, V.2
Balfe, P.3
Vanderhoeven, J.4
Pampuro, S.E.5
Zala, C.6
Ochoa, C.7
Cahn, P.8
Markowitz, M.9
Salomon, H.10
-
44
-
-
0033064963
-
Comparative fitness of multi-dideoxynucleoside-resistant human immunodeficiency virus type 1 (HIV-1) in an in vitro competitive HIV-1 replication assay
-
Kosalaraksa, P., Kavlick, M.F., Maroun, V., Le, R., Mitsuya, H., 1999. Comparative fitness of multi-dideoxynucleoside-resistant human immunodeficiency virus type 1 (HIV-1) in an in vitro competitive HIV-1 replication assay. J. Virol. 73, 5356-5363.
-
(1999)
J. Virol.
, vol.73
, pp. 5356-5363
-
-
Kosalaraksa, P.1
Kavlick, M.F.2
Maroun, V.3
Le, R.4
Mitsuya, H.5
-
45
-
-
0028180236
-
Genetic analysis of HIV-1 isolates from Brazil reveals presence of two distinct genetic subtypes
-
Louwagie, J., Delwart, E.I., Mullins, J.I., McCutchan, F.E., Eddy, G., Burke, D.S., 1994. Genetic analysis of HIV-1 isolates from Brazil reveals presence of two distinct genetic subtypes. AIDS Res. Hum. Retroviruses 10 (5), 561-567.
-
(1994)
AIDS Res. Hum. Retroviruses
, vol.10
, Issue.5
, pp. 561-567
-
-
Louwagie, J.1
Delwart, E.I.2
Mullins, J.I.3
McCutchan, F.E.4
Eddy, G.5
Burke, D.S.6
-
46
-
-
0035281108
-
International perspectives on antiretroviral resistance. Nucleoside reverse transcriptase inhibitor resistance
-
Loveday, C., 2001. International perspectives on antiretroviral resistance. Nucleoside reverse transcriptase inhibitor resistance. J. Acquir. Immune. Defic. Syndr. 26 (Suppl. 1), S10-S24.
-
(2001)
J. Acquir. Immune. Defic. Syndr.
, vol.26
, Issue.SUPPL. 1
-
-
Loveday, C.1
-
47
-
-
0035330599
-
A novel recombinant marker virus assay for comparing the relative fitness of HIV-1 reverse transcriptase variants
-
Lu, J., Kuritzkes, D.R., 2001. A novel recombinant marker virus assay for comparing the relative fitness of HIV-1 reverse transcriptase variants. J. Acquir. Immune. Defic. Syndr. 27, 7-13.
-
(2001)
J. Acquir. Immune. Defic. Syndr.
, vol.27
, pp. 7-13
-
-
Lu, J.1
Kuritzkes, D.R.2
-
48
-
-
0031948662
-
Altered drug sensitivity, fitness, and evolution of human immunodeficiency virus type 1 with pol gene mutations conferring multi-dideoxynucleoside resistance
-
Maeda, Y., Venzon, D.J., Mitsuya, H., 1998. Altered drug sensitivity, fitness, and evolution of human immunodeficiency virus type 1 with pol gene mutations conferring multi-dideoxynucleoside resistance. J. Infect. Dis. 177, 1207-1213.
-
(1998)
J. Infect. Dis.
, vol.177
, pp. 1207-1213
-
-
Maeda, Y.1
Venzon, D.J.2
Mitsuya, H.3
-
49
-
-
0031846317
-
Resistance-associated loss of viral fitness in human immunodeficiency virus type 1: Phenotypic analysis of protease and gag coevolution in protease inhibitor-treated patients
-
Mammano, F., Petit, C., Clavel, F., 1998. Resistance-associated loss of viral fitness in human immunodeficiency virus type 1: phenotypic analysis of protease and gag coevolution in protease inhibitor-treated patients. J. Virol. 72, 7632-7637.
-
(1998)
J. Virol.
, vol.72
, pp. 7632-7637
-
-
Mammano, F.1
Petit, C.2
Clavel, F.3
-
50
-
-
0033863985
-
Retracing the evolutionary pathways of human immunodeficiency virus type 1 resistance to protease inhibitors: Virus fitness in the absence and in the presence of drug
-
Mammano, F., Trouplin, V., Zennou, V., Clavel, F., 2000. Retracing the evolutionary pathways of human immunodeficiency virus type 1 resistance to protease inhibitors: virus fitness in the absence and in the presence of drug. J. Virol. 74, 8524-8531.
-
(2000)
J. Virol.
, vol.74
, pp. 8524-8531
-
-
Mammano, F.1
Trouplin, V.2
Zennou, V.3
Clavel, F.4
-
51
-
-
0028854676
-
Selection and analysis of human immunodeficiency virus type 1 variants with increased resistance to ABT-538, a novel protease inhibitor
-
Markowitz, M., Mo, H., Kempf, D.J., Norbeck, D.W., Bhat, T.N., Erickson, J.W., Ho, D.D., 1995. Selection and analysis of human immunodeficiency virus type 1 variants with increased resistance to ABT-538, a novel protease inhibitor. J. Virol. 69, 701-706.
-
(1995)
J. Virol.
, vol.69
, pp. 701-706
-
-
Markowitz, M.1
Mo, H.2
Kempf, D.J.3
Norbeck, D.W.4
Bhat, T.N.5
Erickson, J.W.6
Ho, D.D.7
-
52
-
-
0034734783
-
Fitness of human immunodeficiency virus type 1 protease inhibitor-selected single mutants
-
Martinez-Picado, J., Savara, A.V., Shi, L., Sutton, L., D'aquila, R.T., 2000. Fitness of human immunodeficiency virus type 1 protease inhibitor-selected single mutants. Virology 275, 318-322.
-
(2000)
Virology
, vol.275
, pp. 318-322
-
-
Martinez-Picado, J.1
Savara, A.V.2
Shi, L.3
Sutton, L.4
D'aquila, R.T.5
-
53
-
-
0032928065
-
Replicative fitness of protease inhibitor-resistant mutants of human immunodeficiency virus type 1
-
Martinez-Picado, J., Savara, A.V., Sutton, L., D'aquila, R.T., 1999. Replicative fitness of protease inhibitor-resistant mutants of human immunodeficiency virus type 1. J. Virol. 73, 3744-3752.
-
(1999)
J. Virol.
, vol.73
, pp. 3744-3752
-
-
Martinez-Picado, J.1
Savara, A.V.2
Sutton, L.3
D'aquila, R.T.4
-
54
-
-
0036642406
-
Reduced levels of CD4 cell spontaneous apoptosis in human immunodeficiency virus-infected patients with discordant response to protease inhibitors
-
Meroni, L., Varchetta, S., Manganaro, D., Gatti, N., Riva, A., Monforte, A., Galli, M., 2002. Reduced levels of CD4 cell spontaneous apoptosis in human immunodeficiency virus-infected patients with discordant response to protease inhibitors. J. Infect. Dis. 186, 143-144.
-
(2002)
J. Infect. Dis.
, vol.186
, pp. 143-144
-
-
Meroni, L.1
Varchetta, S.2
Manganaro, D.3
Gatti, N.4
Riva, A.5
Monforte, A.6
Galli, M.7
-
55
-
-
0035280944
-
International perspectives on antiretroviral resistance. Resistance to protease inhibitors
-
Miller, V., 2001a. International perspectives on antiretroviral resistance. Resistance to protease inhibitors. J. Acquir. Immune. Defic. Syndr. 26 (Suppl. 1), S34-S50.
-
(2001)
J. Acquir. Immune. Defic. Syndr.
, vol.26
, Issue.SUPPL. 1
-
-
Miller, V.1
-
56
-
-
0035146527
-
Structured treatment interruptions in antiretroviral management of HIV-1
-
Miller, V., 2001b. Structured treatment interruptions in antiretroviral management of HIV-1. Curr. Opin. Infect. Dis. 14, 29-37.
-
(2001)
Curr. Opin. Infect. Dis.
, vol.14
, pp. 29-37
-
-
Miller, V.1
-
57
-
-
0033865498
-
Patterns of changes in human immunodeficiency virus type 1 V3 sequence populations late in infection
-
Nelson, J.A., Baribaud, F., Edwards, T., Swanstrom, R., 2000. Patterns of changes in human immunodeficiency virus type 1 V3 sequence populations late in infection. J. Virol. 74, 8494-8501.
-
(2000)
J. Virol.
, vol.74
, pp. 8494-8501
-
-
Nelson, J.A.1
Baribaud, F.2
Edwards, T.3
Swanstrom, R.4
-
58
-
-
0035141001
-
Implications of antiretroviral resistance on viral fitness
-
Nijhuis, M., Deeks, S., Boucher, C., 2001. Implications of antiretroviral resistance on viral fitness. Curr. Opin. Infect. Dis. 14, 23-28.
-
(2001)
Curr. Opin. Infect. Dis.
, vol.14
, pp. 23-28
-
-
Nijhuis, M.1
Deeks, S.2
Boucher, C.3
-
59
-
-
0032804864
-
Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy
-
Nijhuis, M., Schuurman, R., de Jong, D., Erickson, J., Gustchina, E., Albert, J., Schipper, P., Gulnik, S., Boucher, C.A., 1999. Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy. AIDS 13, 2349-2359.
-
(1999)
AIDS
, vol.13
, pp. 2349-2359
-
-
Nijhuis, M.1
Schuurman, R.2
De Jong, D.3
Erickson, J.4
Gustchina, E.5
Albert, J.6
Schipper, P.7
Gulnik, S.8
Boucher, C.A.9
-
60
-
-
0035818544
-
Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects
-
Ortiz, G.M., Wellons, M., Brancato, J., Vo, H.T., Zinn, R.L., Clarkson, D.E., Van Loon, K., Bonhoeffer, S., Miralles, G.D., Montefiori, D., Bartlett, J.A., Nixon, D.F., 2001. Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects. Proc. Natl. Acad. Sci. U.S.A. 98, 13288-13293.
-
(2001)
Proc. Natl. Acad. Sci. U.S.A.
, vol.98
, pp. 13288-13293
-
-
Ortiz, G.M.1
Wellons, M.2
Brancato, J.3
Vo, H.T.4
Zinn, R.L.5
Clarkson, D.E.6
Van Loon, K.7
Bonhoeffer, S.8
Miralles, G.D.9
Montefiori, D.10
Bartlett, J.A.11
Nixon, D.F.12
-
61
-
-
0029896360
-
Kinetic characterization of human immunodeficiency virus type-1 protease-resistant variants
-
Pazhanisamy, S., Stuver, C.M., Cullinan, A.B., Margolin, N., Rao, B.G., Livingston, D.J., 1996. Kinetic characterization of human immunodeficiency virus type-1 protease-resistant variants. J. Biol. Chem. 271, 17979-17985.
-
(1996)
J. Biol. Chem.
, vol.271
, pp. 17979-17985
-
-
Pazhanisamy, S.1
Stuver, C.M.2
Cullinan, A.B.3
Margolin, N.4
Rao, B.G.5
Livingston, D.J.6
-
62
-
-
0034019566
-
A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1
-
Petropoulos, C.J., Parkin, N.T., Limoli, K.L., Lie, Y.S., Wrin, T., Huang, W., Tian, H., Smith, D., Winslow, G.A., Capon, D.J., Whitcomb, J.M., 2000. A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1. Antimicrob. Agents Chemother. 44, 920-928.
-
(2000)
Antimicrob. Agents Chemother.
, vol.44
, pp. 920-928
-
-
Petropoulos, C.J.1
Parkin, N.T.2
Limoli, K.L.3
Lie, Y.S.4
Wrin, T.5
Huang, W.6
Tian, H.7
Smith, D.8
Winslow, G.A.9
Capon, D.J.10
Whitcomb, J.M.11
-
63
-
-
0034492631
-
Altered viral fitness of HIV-1 following failure of protease inhibitor-based therapy
-
Picchio, G.R., Valdez, H., Sabbe, R., Landay, A.L., Kuritzkes, D.R., Lederman, M.M., Mosier, D.E., 2000. Altered viral fitness of HIV-1 following failure of protease inhibitor-based therapy. J. Acquir. Immune. Defic. Syndr. 25, 289-295.
-
(2000)
J. Acquir. Immune. Defic. Syndr.
, vol.25
, pp. 289-295
-
-
Picchio, G.R.1
Valdez, H.2
Sabbe, R.3
Landay, A.L.4
Kuritzkes, D.R.5
Lederman, M.M.6
Mosier, D.E.7
-
64
-
-
0034040118
-
Reservoirs for HIV-1: Mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy
-
Pierson, T., McArthur, J., Siliciano, R.F., 2000. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy. Annu. Rev. Immunol. 18, 665-708.
-
(2000)
Annu. Rev. Immunol.
, vol.18
, pp. 665-708
-
-
Pierson, T.1
McArthur, J.2
Siliciano, R.F.3
-
65
-
-
0035341522
-
Long-term clinical outcome of human immunodeficiency virus-infected patients with discordant immunologic and virologic responses to a protease inhibitor-containing regimen
-
Piketty, C., Weiss, L., Thomas, E, Mohamed, A.S., Belec, L., Kazatchkine, M.D., 2001. Long-term clinical outcome of human immunodeficiency virus-infected patients with discordant immunologic and virologic responses to a protease inhibitor-containing regimen. J. Infect. Dis. 183, 1328-1335.
-
(2001)
J. Infect. Dis.
, vol.183
, pp. 1328-1335
-
-
Piketty, C.1
Weiss, L.2
Thomas, E.3
Mohamed, A.S.4
Belec, L.5
Kazatchkine, M.D.6
-
66
-
-
0037012979
-
Amprenavir resistant HIV-1 exhibits lopinavir cross-resistance and reduced replication capacity
-
Prado, J.G., Wrin, T., Beauchaine, J., Ruiz, L., Petropoulos, C.J., Frost, S.D., Clotet, B., D'aquila, R.T., Martinez-Picado, J., 2002. Amprenavir resistant HIV-1 exhibits lopinavir cross-resistance and reduced replication capacity. AIDS 16 (7), 1009-1017.
-
(2002)
AIDS
, vol.16
, Issue.7
, pp. 1009-1017
-
-
Prado, J.G.1
Wrin, T.2
Beauchaine, J.3
Ruiz, L.4
Petropoulos, C.J.5
Frost, S.D.6
Clotet, B.7
D'aquila, R.T.8
Martinez-Picado, J.9
-
67
-
-
0001769435
-
HIV-1 fitness: Implications for drug resistance, disease progression, and global epidemic evolution
-
Kuiken, C., Foley, B., Hahn, B., Marx, P., McCutchan, F., Mellors, J., Wolinsky, S., Korber, B. (Eds.), Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM
-
Quiñones-Mateu, M.E., Arts, E.J., 2001. HIV-1 fitness: implications for drug resistance, disease progression, and global epidemic evolution. In: Kuiken, C., Foley, B., Hahn, B., Marx, P., McCutchan, F., Mellors, J., Wolinsky, S., Korber, B. (Eds.), HIV Sequence Compendium 2001, Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM, pp. 134-170.
-
(2001)
HIV Sequence Compendium 2001
, pp. 134-170
-
-
Quiñones-Mateu, M.E.1
Arts, E.J.2
-
68
-
-
0033803642
-
A dual infection/competition assay shows a correlation between ex vivo human immunodeficiency virus type 1 fitness and disease progression
-
Quiñones-Mateu, M.E., Ball, S.C., Marozsan, A.J., Torre, V.S., Albright, J.L., Vanham, G., van der, G.G., Colebunders, R.L., Arts, E.J., 2000. A dual infection/competition assay shows a correlation between ex vivo human immunodeficiency virus type 1 fitness and disease progression. J. Virol. 74, 9222-9233.
-
(2000)
J. Virol.
, vol.74
, pp. 9222-9233
-
-
Quiñones-Mateu, M.E.1
Ball, S.C.2
Marozsan, A.J.3
Torre, V.S.4
Albright, J.L.5
Vanham, G.6
Van der, G.G.7
Colebunders, R.L.8
Arts, E.J.9
-
69
-
-
12244288050
-
A novel TaqMan real-time PCR method to estimate HIV-1 fitness in the era of multi-target antiretroviral therapy
-
Seville, Spain
-
Quiñones-Mateu, M.E., Weber, J., Rangel, H.R., Chakraborty, B., Martinez, M.A., Este, J.A., Martinez-Picado, J., Ruiz, L., Clotet, B., Wrin, T., Petropoulos, C.J., 2002. A novel TaqMan real-time PCR method to estimate HIV-1 fitness in the era of multi-target antiretroviral therapy. In: Proceedings of the XI International HIV Drug Resistance Meeting, Seville, Spain.
-
(2002)
Proceedings of the XI International HIV Drug Resistance Meeting
-
-
Quiñones-Mateu, M.E.1
Weber, J.2
Rangel, H.R.3
Chakraborty, B.4
Martinez, M.A.5
Este, J.A.6
Martinez-Picado, J.7
Ruiz, L.8
Clotet, B.9
Wrin, T.10
Petropoulos, C.J.11
-
70
-
-
0031571885
-
Population dynamics studies of wild-type and drug-resistant mutant HIV in mixed infections
-
Rayner, M.M., Cordova, B., Jackson, D.A., 1997. Population dynamics studies of wild-type and drug-resistant mutant HIV in mixed infections. Virology 236, 85-94.
-
(1997)
Virology
, vol.236
, pp. 85-94
-
-
Rayner, M.M.1
Cordova, B.2
Jackson, D.A.3
-
71
-
-
0035793118
-
A multiple-site-specific heteroduplex tracking assay as a tool for the study of viral population dynamics
-
Resch, W., Parkin, N., Stuelke, E.L., Watkins, T., Swanstrom, R., 2001. A multiple-site-specific heteroduplex tracking assay as a tool for the study of viral population dynamics. Proc. Natl. Acad. Sci. U.S.A. 98, 176-181.
-
(2001)
Proc. Natl. Acad. Sci. U.S.A.
, vol.98
, pp. 176-181
-
-
Resch, W.1
Parkin, N.2
Stuelke, E.L.3
Watkins, T.4
Swanstrom, R.5
-
72
-
-
0036337934
-
Nelfinavir-resistant, amprenavir-hypersusceptible strains of human immunodeficiency virus type 1 carrying an N88S mutation in protease have reduced infectivity, reduced replication capacity, and reduced fitness and process the Gag polyprotein precursor aberrantly
-
Resch, W., Ziermann, R., Parkin, N., Gamamik, A., Swanstrom, R., 2002. Nelfinavir-resistant, amprenavir-hypersusceptible strains of human immunodeficiency virus type 1 carrying an N88S mutation in protease have reduced infectivity, reduced replication capacity, and reduced fitness and process the Gag polyprotein precursor aberrantly. J. Virol. 76, 8659-8666.
-
(2002)
J. Virol.
, vol.76
, pp. 8659-8666
-
-
Resch, W.1
Ziermann, R.2
Parkin, N.3
Gamamik, A.4
Swanstrom, R.5
-
73
-
-
0037016482
-
Discordant immunological response in HIV-positive patients on non-nucleoside reverse transcriptase inhibitor-based regimens
-
Ripamonti, D., Arici, C., Maggiolo, F., Finazzi, M.G., Suter, F., 2002. Discordant immunological response in HIV-positive patients on non-nucleoside reverse transcriptase inhibitor-based regimens. AIDS 16, 130-131.
-
(2002)
AIDS
, vol.16
, pp. 130-131
-
-
Ripamonti, D.1
Arici, C.2
Maggiolo, F.3
Finazzi, M.G.4
Suter, F.5
-
74
-
-
0034632745
-
HIV type 1 protease cleavage site mutations and viral fitness: Implications for drug susceptibility phenotyping assays
-
Robinson, L.H., Myers, R.E., Snowden, B.W., Tisdale, M., Blair, E.D., 2000. HIV type 1 protease cleavage site mutations and viral fitness: implications for drug susceptibility phenotyping assays. AIDS Res. Hum. Retroviruses 16, 1149-1156.
-
(2000)
AIDS Res. Hum. Retroviruses
, vol.16
, pp. 1149-1156
-
-
Robinson, L.H.1
Myers, R.E.2
Snowden, B.W.3
Tisdale, M.4
Blair, E.D.5
-
75
-
-
0034030441
-
Memory in viral quasispecies
-
Ruiz-Jarabo, C.M., Arias, A., Baranowski, E., Escarmis, C., Domingo, E., 2000. Memory in viral quasispecies. J. Virol. 74, 3543-3547.
-
(2000)
J. Virol.
, vol.74
, pp. 3543-3547
-
-
Ruiz-Jarabo, C.M.1
Arias, A.2
Baranowski, E.3
Escarmis, C.4
Domingo, E.5
-
76
-
-
0030768138
-
Attenuated replication of human immunodeficiency virus type 1 with a didanosine-selected reverse transcriptase mutation
-
published erratum appears in J Virol 1998 Apr;72(4):3504
-
Sharma, P.L., Crumpacker, C.S., 1997. Attenuated replication of human immunodeficiency virus type 1 with a didanosine-selected reverse transcriptase mutation [published erratum appears in J Virol 1998 Apr;72(4):3504]. J. Virol. 71, 8846-8851.
-
(1997)
J. Virol.
, vol.71
, pp. 8846-8851
-
-
Sharma, P.L.1
Crumpacker, C.S.2
-
77
-
-
0032875344
-
Decreased processivity of human immunodeficiency virus type 1 reverse transcriptase (RT) containing didanosine-selected mutation Leu74Val: A comparative analysis of RT variants Leu74Val and lamivudine-selected Met184Val
-
Sharma, P.L., Crumpacker, C.S., 1999. Decreased processivity of human immunodeficiency virus type 1 reverse transcriptase (RT) containing didanosine-selected mutation Leu74Val: a comparative analysis of RT variants Leu74Val and lamivudine-selected Met184Val. J. Virol. 73, 8448-8456.
-
(1999)
J. Virol.
, vol.73
, pp. 8448-8456
-
-
Sharma, P.L.1
Crumpacker, C.S.2
-
78
-
-
0030816830
-
A recombinant retroviral system for rapid in vivo analysis of human immunodeficiency virus type 1 susceptibility to reverse transcriptase inhibitors
-
Shi, C., Mellors, J.W., 1997. A recombinant retroviral system for rapid in vivo analysis of human immunodeficiency virus type 1 susceptibility to reverse transcriptase inhibitors. Antimicrob. Agents Chemother. 41, 2781-2785.
-
(1997)
Antimicrob. Agents Chemother.
, vol.41
, pp. 2781-2785
-
-
Shi, C.1
Mellors, J.W.2
-
79
-
-
0034948377
-
Impaired replication of protease inhibitor-resistant HIV-1 in human thymus
-
Stoddart, C.A., Liegler, T.J., Mammano, F., Linquist-Stepps, V.D., Hayden, M.S., Deeks, S.G., Grant, R.M., Clavel, F., McCune, J.M., 2001. Impaired replication of protease inhibitor-resistant HIV-1 in human thymus. Nat. Med. 7, 712-718.
-
(2001)
Nat. Med.
, vol.7
, pp. 712-718
-
-
Stoddart, C.A.1
Liegler, T.J.2
Mammano, F.3
Linquist-Stepps, V.D.4
Hayden, M.S.5
Deeks, S.G.6
Grant, R.M.7
Clavel, F.8
McCune, J.M.9
-
80
-
-
0033389039
-
Interruption of reverse transcriptase inhibitors or a switch from reverse transcriptase to protease inhibitors resulted in a fast reappearance of virus strains with a reverse transcriptase inhibitor-sensitive genotype
-
Verhofstede, C., Wanzeele, F.V., Van Der, G.B., De Cabooter, N., Plum, J., 1999. Interruption of reverse transcriptase inhibitors or a switch from reverse transcriptase to protease inhibitors resulted in a fast reappearance of virus strains with a reverse transcriptase inhibitor-sensitive genotype. AIDS 13, 2541-2546.
-
(1999)
AIDS
, vol.13
, pp. 2541-2546
-
-
Verhofstede, C.1
Wanzeele, F.V.2
Van Der, G.B.3
De Cabooter, N.4
Plum, J.5
-
81
-
-
0036603295
-
"Discordant" increases in CD4 cell count relative to plasma viral load in a closely followed cohort of patients initiating antiretroviral therapy
-
Wood, E., Hogg, R.S., Yip, B., Tyndall, M.W., Sherlock, C.H., Harrigan, R.P., O'Shaughnessy, M.V., Montaner, J.S., 2002. "Discordant" increases in CD4 cell count relative to plasma viral load in a closely followed cohort of patients initiating antiretroviral therapy. J. Acquir. Immune. Defic. Syndr. 30, 159-166.
-
(2002)
J. Acquir. Immune. Defic. Syndr.
, vol.30
, pp. 159-166
-
-
Wood, E.1
Hogg, R.S.2
Yip, B.3
Tyndall, M.W.4
Sherlock, C.H.5
Harrigan, R.P.6
O'Shaughnessy, M.V.7
Montaner, J.S.8
-
82
-
-
0042221195
-
Natural variation of replication capacity measurements in drug-naive/susceptible HIV-1
-
Scottsdale, Arizona, June 2001, Abstract 24
-
Wrin, T., Gamarnik, A., Whitehurst, N., Beauchaine, J., Whitcomb, J.M., Hellmann, N.S., Petropoulos, C.J., 2001. Natural variation of replication capacity measurements in drug-naive/susceptible HIV-1. In: Proceedings of the 5th International Workshop on HIV Drug Resistance & Treatment Strategies, Scottsdale, Arizona, June 2001, Abstract 24.
-
(2001)
Proceedings of the 5th International Workshop on HIV Drug Resistance & Treatment Strategies
-
-
Wrin, T.1
Gamarnik, A.2
Whitehurst, N.3
Beauchaine, J.4
Whitcomb, J.M.5
Hellmann, N.S.6
Petropoulos, C.J.7
-
83
-
-
0031977656
-
Switch to unusual amino acids at codon 215 of the human immunodeficiency virus type 1 reverse transcriptase gene in seroconvertors infected with zidovudine-resistant variants
-
Yerly, S., Rakik, A., De Loes, S.K., Hirschel, B., Descamps, D., Brun-Vezinet, F., Perrin, L., 1998. Switch to unusual amino acids at codon 215 of the human immunodeficiency virus type 1 reverse transcriptase gene in seroconvertors infected with zidovudine-resistant variants. J. Virol. 72, 3520-3523.
-
(1998)
J. Virol.
, vol.72
, pp. 3520-3523
-
-
Yerly, S.1
Rakik, A.2
De Loes, S.K.3
Hirschel, B.4
Descamps, D.5
Brun-Vezinet, F.6
Perrin, L.7
-
84
-
-
0033609373
-
Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy
-
Zhang, L., Ramratnam, B., Tenner-Racz, K., He, Y., Vesanen, M., Lewin, S., Talal, A., Racz, P., Perelson, A.S., Korber, B.T., Markowitz, M., Ho, D.D., 1999. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy. N. Engl. J. Med. 340, 1605-1613.
-
(1999)
N. Engl. J. Med.
, vol.340
, pp. 1605-1613
-
-
Zhang, L.1
Ramratnam, B.2
Tenner-Racz, K.3
He, Y.4
Vesanen, M.5
Lewin, S.6
Talal, A.7
Racz, P.8
Perelson, A.S.9
Korber, B.T.10
Markowitz, M.11
Ho, D.D.12
|